I am ashwinicmi (ashwini.bakhade@coherentmarketinsights.com). I hold full responsibility for this content, which includes text, images, links, and files. The website administrator and team cannot be held accountable for this content. If there is anything you need to discuss, you can reach out to me via ashwini.bakhade@coherentmarketinsights.com email.

Disclaimer: The domain owner, admin and website staff of Reviews Consumer Reports, had no role in the preparation of this post. Reviews Consumer Reports, does not accept liability for any loss or damages caused by the use of any links, images, texts, files, or products, nor do we endorse any content posted in this website.

Growing Prevalence of Lung Diseases Driving Demand for Lung Stent Industry

The global lung stent market has been witnessing strong growth owing to the rising incidence of lung diseases globally. According to the Global Burden of Disease Study, chronic obstructive pulmonary disease (COPD) affected over 251 million people worldwide in 2016. The increasing geriatric population is another key factor fueling the prevalence of various respiratory disorders since aging is one of the biggest risk factors for COPD and lung cancer. As per the WHO, by 2050, the population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. The growing cases of lung diseases are propelling the demand for minimally invasive procedures using lung stents for treatment.

Metal Lung Stent Industry Dominate the Market

Based on material, the Global Lung Stent has been divided into metal and non-metal stents. In 2020, the metal lung stents segment accounted for the larger share of over 70%. This as metal stents have been the standard stenting option owing to their mechanical strength and radiopacity. Moreover, metal stents experience less tissue hyperplasia and have a lower risk of migration as compared to non-metal variants. Some of the commonly used metal materials for lung stenting include nitinol and stainless steel owing to their flexibility, durability, biocompatibility, and radiopacity. However, non-metal/bioresorbable stents are gaining traction gradually due to advantages such as reduced risk of inflammation and Migration.

Self-expandable Stents Witness Higher Demand

In terms of product, the global lung stent market has been categorized into self-expandable and non-expandable stents. Self-expandable stents commanded the dominant market share in 2020 as they offer advantages such as easy insertion through narrow lumen and reduced risk of tissue damage. Self-expandable stents apply continuous and uniform radial force to ensure proper functioning of the airways. Some key self-expandable lung stent types available in the market are metallic mesh stents and bioresorbable stent implants. On the other hand, balloon-expandable stents require complex procedures involving balloon inflation and deflation during insertion.

Bronchial Lung Stents Hold Major Share

Based on application, the global lung stent market covers bronchial and tracheal procedures. Of these, the bronchial lung stents segment held a sizable market share in 2020. This is because bronchial stenosis is a commonly occurring complication post lobectomy, leading to high demand for bronchial stents. Tracheal stenosis is relatively less frequent, thus impacting the adoption of tracheal lung stents. However, with increasing preference for minimally invasive procedures, the tracheal lung stents segment is expected to witness faster growth over the forecast period.

Hospitals Generate Maximum Revenue

The global lung stent market has also been categorized based on end-user into hospitals, ambulatory surgical centers, and others. Hospitals accounted for the bulk of the total market revenue in 2020. This is owing to the high patient preference for hospitals for respiratory care along with availability of advanced diagnostic and therapy options. In addition, a large number of complex airway obstruction cases requiring lung stenting procedures are managed in hospitals. However, the ambulatory surgical centers segment is likely to exhibit faster growth driven by benefits such as lower cost of care, reduced waiting periods, and convenience.

North America Dominates Global Market

North America held the leading share in the global lung stent market in 2020 driven by significant patient population, rising lung cancer burden, favorable reimbursement coverage, technological advancement, and healthcare investments.

Europe occupied the second position attributable to the increasing COPD prevalence and supportive regulatory environment for novel lung stents. Asia-Pacific is poised to witness the fastest growth throughout the forecast period credit to improving access to healthcare, economic expansion, and establishment of key market players in countries such as China and India.

Get more insights on This Topic- Global Lung Stent